A new strategy for preparing molecular imaging and therapy agents using fluorine-rich (fluorous) soluble supports

被引:39
作者
Donovan, A
Forbes, J
Dorff, P
Schaffer, P
Babich, J
Valliant, JF [1 ]
机构
[1] McMaster Univ, Dept Chem, Hamilton, ON L8S 4M1, Canada
[2] McMaster Univ, Dept Med Phys & Appl Radiat Sci, Hamilton, ON L8S 4M1, Canada
[3] Mol Insight Pharmaceut Inc, Cambridge, MA 02142 USA
关键词
D O I
10.1021/ja0600375
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
A convenient new strategy for producing radiolabeled compounds in high effective specific activity was developed using soluble fluorous supports. The reported methodology involves a fluorous linker group that is released from the substrate of interest upon reaction with radioiodine. The desired product can then be selectively separated from unreacted starting material and reaction byproducts using a simple fluorous solid-phase extraction procedure. The utility of this approach was demonstrated by labeling a series of benzoic acid derivatives which are commonly used to prepare molecular imaging agents. All compounds were produced in high radiochemical yields, purities, and effective specific activities. The strategy was further elaborated in that it was used to prepare a small collection of radiolabeled benzamides as a way of demonstrating the potential utility of this method for creating libraries of molecular imaging agents. Copyright © 2006 American Chemical Society.
引用
收藏
页码:3536 / 3537
页数:2
相关论文
共 23 条
[1]   A potential melanoma tracer:: Synthesis, radiolabeling, and biodistribution in mice of a new nitridotechnetium bis(aminothiol) derivative pharmacomodulated by a N-(diethylaminoethyl)benzamide [J].
Auzeloux, P ;
Papon, J ;
Azim, EM ;
Borel, M ;
Pasqualini, R ;
Veyre, A ;
Madelmont, JC .
JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (02) :190-198
[2]   Perfluorocarbon-soluble catalysts and reagents and the application of FBS (fluorous biphase system) to organic synthesis [J].
Cavazzini, M ;
Montanari, F ;
Pozzi, G ;
Quici, S .
JOURNAL OF FLUORINE CHEMISTRY, 1999, 94 (02) :183-193
[3]   POLYMER-SUPPORTED RADIOPHARMACEUTICALS - I-123 LABELED AND I-131-LABELED N-ISOPROPYL-4-IODOAMPHETAMINE [J].
CULBERT, PA ;
HUNTER, DH .
REACTIVE POLYMERS, 1993, 19 (03) :247-253
[4]  
Curran D.P., 2004, HDB FLUOROUS CHEM
[5]  
Curran DP, 2001, SYNLETT, P1488
[6]   A solid-phase technique for preparation of no-carrier-added technetium-99m radiopharmaceuticals: Application to the streptavidin/biotin system [J].
Dunn-Dufault, R ;
Pollak, A ;
Fitzgerald, J ;
Thornback, JR ;
Ballinger, JR .
NUCLEAR MEDICINE AND BIOLOGY, 2000, 27 (08) :803-807
[7]   Accelerating drug discovery and development through in vivo imaging [J].
Eckelman, WC .
NUCLEAR MEDICINE AND BIOLOGY, 2002, 29 (08) :777-782
[8]   Melanoma uptake of 99mTc complexes containing the N-(2-diethylaminoethyl)benzamide structural element [J].
Eisenhut, M ;
Mohammed, A ;
Mier, W ;
Schönsiegel, F ;
Friebe, M ;
Mahmood, A ;
Jones, AG ;
Haberkorn, U .
JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (26) :5802-5805
[9]  
Flanagan R. J., 1989, US, Patent No. 4874601
[10]   Palladium-catalyzed Stille couplings with fluorous tin reactants [J].
Hoshino, M ;
Degenkolb, P ;
Curran, DP .
JOURNAL OF ORGANIC CHEMISTRY, 1997, 62 (24) :8341-8349